CPRIT approves $12 million to bring top-flight cancer researchers to Lone Star State

(AUSTIN) The governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment grants in its quarterly meeting at the Texas Capitol on Wednesday. The grants will bring two CPRIT Scholars from out-of-state institutions to Texas to expand their cancer research and add to the state’s growing cancer research prowess.

CPRIT responds to New England Journal of Medicine Colonoscopy Study

The U.S. Preventive Services Task Force and the American Cancer Society have recommended routine cancer screening for colorectal cancer for several decades, with colonoscopy being the predominant form of screening for colorectal cancer in the United States. Despite questions raised by a recent Nordic-European Initiative on Colorectal Cancer (NordICC) study regarding the relative value of colonoscopy, CPRIT recommends that adults continue following established guidelines to undergo regular colorectal cancer screening, including colonoscopy, beginning at age 45.

CPRIT encourages Texans to apply for national ARPA-H Program Manager

This year, the federal government established the Advanced Research Projects Agency for Health (ARPA-H), a new agency to catalyze transformative high-risk, high-reward research to drive biomedical and health breakthroughs that will transform medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity.

President Biden recently named Dr. Renee Wegrzyn as the first director of the agency.  A home site for the agency has not yet been determined.

State cancer agency approves $49 million in new research grants

(AUSTIN) Today, the Oversight Committee of the Cancer Prevention and Research Institute of Texas (CPRIT), held a special meeting to approve a slate of awards totaling $48,923,075 for cancer research and product development. The list of grants is included at the bottom of this release.

“Today, the CPRIT Oversight Committee raised the bar on the fight against cancer,” said CPRIT CEO Wayne Roberts. “These grants continue to fund the path forward for cancer research in the state of Texas and provide vital financial support for the researchers, labs and institutions on the frontline of this monumental statewide effort to end cancer as we know it.”

The CPRIT Innovations Conference VI Returns in 2023

CPRIT is proud to announce our Innovations in Cancer Prevention and Research Conference VI returns in-person October 2 - 3, 2023 at Moody Gardens Hotel, Spa and Convention Center in beautiful Galveston, Texas. (more)

CPRIT Releases Four Product Development Research Funding Opportunities (Cycle 23.1 RFAs)

CPRIT announces the release of four (4) Requests for Applications (RFAs) for FY 2023 Product Development Research grants. Complete RFAs and instructions are available in the “Apply for Funding” section of CPRIT’s website.

•    Texas Therapeutics Company Product Development Research Award (TTC)
•    Texas Diagnostics and Devices Company Product Development Research Award (TDDC)
•    Texas New Technologies Company Product Development Research Award (TNTC)
•    Seed Awards for Product Development Research (SEED)